Taiwan's Biopharm To Expand Meter-Dose Inhaler Production
This article was originally published in PharmAsia News
Executive Summary
Biopharm plans to spend more than $33 million over the next three years expanding its Taiwan facilities dedicated to making its metered-dose inhalers so it can produce 30 million a year.